Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
- PMID: 8892659
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
Abstract
The vigorous CTL response directed against HIV is considered to be important in reducing HIV viral load, although it is unable to stop ongoing viral replication, which generates new antigenic variants. We analyzed the impact of sequential changes in five epitopes of HIV-1 Nef on CTL recognition in four stable patients. A high rate of variation was found, and in all these patients we could detect CTL specific for 32 out of 36 autologous viral variants occurring in 5 HLA-A2- or HLA-B7-restricted Nef epitopes at two time points. Two distinct patterns for dynamics of CTL responses to viral variation were observed: 1) temporary amplification of viral variants followed by expansion of variant-specific CTL, ultimately leading to the disappearance of 12 out of the 14 initial epitope variants within two years. A second set of viral variants that had replaced the initial ones could also stimulate specific CTL precursors in the context of the same or an alternative HLA molecule; and 2) persistence of 2 viral variants in relatively conserved epitopes despite specific CTL recognition. Therefore, a remarkable flexibility of the immune system allows constant adaptation of CTL to multiple HIV variants and thus elimination of HIV variant-producing cells in slow progressors.
Similar articles
-
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.J Immunol. 1998 Nov 1;161(9):4875-81. J Immunol. 1998. PMID: 9794421
-
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327
-
HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.Eur J Immunol. 1995 Mar;25(3):728-32. doi: 10.1002/eji.1830250315. Eur J Immunol. 1995. PMID: 7705402
-
The cytotoxic T-lymphocyte response in HIV-1 infection.Clin Lab Med. 1994 Jun;14(2):271-99. Clin Lab Med. 1994. PMID: 7924192 Review.
-
Dynamics of HIV variants and specific cytotoxic T-cell recognition in nonprogressors and progressors.Immunol Lett. 1997 Jun 1;57(1-3):63-8. doi: 10.1016/s0165-2478(97)00076-x. Immunol Lett. 1997. PMID: 9232427 Review.
Cited by
-
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.J Virol. 2005 Oct;79(20):12952-60. doi: 10.1128/JVI.79.20.12952-12960.2005. J Virol. 2005. PMID: 16188997 Free PMC article.
-
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.J Virol. 2000 Oct;74(19):9306-12. doi: 10.1128/jvi.74.19.9306-9312.2000. J Virol. 2000. PMID: 10982378 Free PMC article.
-
Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.J Exp Med. 2000 Jan 17;191(2):239-52. doi: 10.1084/jem.191.2.239. J Exp Med. 2000. PMID: 10637269 Free PMC article.
-
Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity.Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8027-32. doi: 10.1073/pnas.97.14.8027. Proc Natl Acad Sci U S A. 2000. PMID: 10884430 Free PMC article.
-
Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames.J Exp Med. 2004 Apr 19;199(8):1053-63. doi: 10.1084/jem.20031869. Epub 2004 Apr 12. J Exp Med. 2004. PMID: 15078897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials